{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T03:30:27Z","timestamp":1776137427134,"version":"3.50.1"},"reference-count":0,"publisher":"Lumitext Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Pharmacol"],"published-print":{"date-parts":[[2009,8,4]]},"DOI":"10.4255\/mcpharmacol.09.16","type":"journal-article","created":{"date-parts":[[2009,8,18]],"date-time":"2009-08-18T22:53:19Z","timestamp":1250635999000},"page":"124-129","source":"Crossref","is-referenced-by-count":34,"title":["Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway"],"prefix":"10.4255","volume":"1","author":[{"given":"Ling-Hui","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2776","container-title":["Molecular and Cellular Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2011,3,14]],"date-time":"2011-03-14T16:17:12Z","timestamp":1300119432000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mcpharmacol.com\/index.php\/Journals\/article\/viewFile\/27\/32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,4]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8,4]]}},"URL":"https:\/\/doi.org\/10.4255\/mcpharmacol.09.16","relation":{},"ISSN":["1938-1247"],"issn-type":[{"value":"1938-1247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,4]]}}}